454 results
Page 11 of 23
POSASR
1g9julwxbjhoeai
26 Aug 11
Automatic shelf registration (post-effective amendment)
12:00am
6-K
zgsfiz
4 Aug 11
Current report (foreign)
12:00am
POSASR
mj2k5sf dan5ia3gfrm
29 Jul 11
Automatic shelf registration (post-effective amendment)
12:00am
POSASR
EX-23.1
ll2 lzf61kqvhcbt4
29 Jul 11
Automatic shelf registration (post-effective amendment)
12:00am
POSASR
EX-5.5
w59t5dt4 ln
29 Jul 11
Automatic shelf registration (post-effective amendment)
12:00am
POSASR
EX-5.4
ezrza0
29 Jul 11
Automatic shelf registration (post-effective amendment)
12:00am
6-K
EX-2.2
keg6t
28 Jul 11
Current report (foreign)
12:00am
6-K
EX-2.3
92z2 8no347k03vm
28 Jul 11
Current report (foreign)
12:00am
6-K
EX-2.5
gw330z
28 Jul 11
Current report (foreign)
12:00am
6-K
EX-2.4
bz3x180je0wth3tpuiu
28 Jul 11
Current report (foreign)
12:00am
6-K
7krp03ab
28 Jul 11
Current report (foreign)
12:00am
6-K
mdgdrh
11 May 11
Current report (foreign)
12:00am
6-K
fjwilf kngrs73zczx
11 May 11
Current report (foreign)
12:00am
6-K
EX-2.1
uuczjaim9i i0ki
3 May 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
0pnl6uvv
12 Apr 11
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
12:00am
6-K
EX-4.1
qcwb6j9alqo8n
21 Mar 11
Current report (foreign)
12:00am
6-K
EX-4.2
z30 m48doo8rdo
21 Mar 11
Current report (foreign)
12:00am
6-K
EX-1.1
6eelssa dovar8z
21 Mar 11
Current report (foreign)
12:00am
6-K
EX-5.2
wjh10 qujapwwpb
21 Mar 11
Current report (foreign)
12:00am
424B5
9fui4m42
17 Mar 11
Prospectus supplement for primary offering
12:00am